Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSanford Health

About this trial

The purpose of this study is to look at pain management with opioids versus non-opioids after knee arthroscopy. This study will determine 1) whether the most commonly used non-narcotic medications provide pain relief comparable with the most commonly prescribed narcotic medications in patients undergoing arthroscopic knee surgery, and 2) whether patients' characteristics (gender, pre-operative knee symptoms, workers compensation status and employment status) affect pain level following surgery or medication usage.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subjects ≥ 18 years of age through ≤ 80 years of age

Subjects undergoing elective arthroscopic knee surgery, to include partial meniscectomy, chondroplasty, or loose body removal.

Disqualifiers

Previously enrolled in this study (enrolled for contralateral knee in this study)

Knee arthroscopy patients scheduled for knee ligament reconstructions

Bilateral knee arthroscopy

History of chronic opioid use or long-term analgesic therapy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Norco 5Mg-325Mg Tablet

    Drug

    1 tablet up to 4 times per day for 7 days

  • Ibuprofen 600 mg

    Drug

    1 tablet up to 4 times per day for 7 days

  • Acetaminophen 325Mg Tab

    Drug

    1 tablet up to 4 times per day for 7 days

Treatment groups

148 Participants
are divided into 2 treatment groups
Group A: OpioidActive comparator 1 intervention
Group B: Non-opioidActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Change from Baseline Pain Assessment at 2 weeks

Visual Analog Scale from 0 to 10 with 0 being no pain and 10 being worst possible, unbearable, excruciating pain

Time frame
Daily for 2 weeks post-operatively
2

Change from Baseline Medication Use at 2 weeks

Patients will be asked how many study medication capsules have they taken.

Time frame
Daily for 14 days post-operatively

Secondary outcomes

1

Change from Baseline Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 weeks

Sub-scales are listed as follows: 5 qualitative questions related to knee symptoms ranging from "never" to "always", 2 qualitative questions related to knee stiffness ranging from "none" to "extreme", 9 qualitative questions related to pain ranging from "none" to "extreme", 17 qualitative questions related to function and daily living ranging from "none" to "extreme", 5 qualitative questions related to function and sports and recreational activities ranging from "none" to "extreme", and 4 qualitative questions related to quality of life ranging from "never or not at all" to "constantly, totally, or extreme".

Time frame
baseline, 2 weeks, and 6 weeks post-operatively
2

Change from Baseline Patient Reported Outcome Measurement Information System (PROMIS) at 6 weeks

7 qualitative questions related to pain interference with responses ranging from "not at all" to "very much"

Time frame
baseline, 2 weeks, and 6 weeks post-operatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.